Lonza (LONN.SW) › Analysis

Lonza Group AG (LONN.SW) maintains strong bullish case

Published November 20, 2026 · LONN.SW chart, levels and live analysis

Lonza Group AG reported a strategic shift toward a pure‑play CDMO model and a 26% revenue lift, while the shares slipped to CHF 652.4 after a 3% pull‑back from the 52‑week high of CHF 672.4. The balance of evidence still leans positive for the next two‑to‑six weeks, with the stock holding above the key structural level of CHF 650 and a breakout math that offers more than a 3‑to‑1 reward‑to‑risk profile.

Why it matters

At the Jefferies Global Healthcare Conference on November 18, Lonza outlined an CHF 8 billion capex pipeline aimed at pure‑play contract development and manufacturing (CDMO) growth, citing a 26% revenue increase over the prior twelve months and an EBITDA margin expansion of four percentage points. The announcement reinforced the company’s positioning in high‑growth markets such as viral vector and cell‑therapy manufacturing, which are projected to expand at double‑digit rates through 2035 (GlobeNewswire). The market reacted by pricing in the upside potential, as evidenced by the stock’s 5‑day outperformance of the S&P 500 (+15.5%) and the healthcare sector XLV (+7.4%).

That outperformance was already baked into the price before the conference. The stock closed at CHF 672.4 on November 4, the 52‑week high, and then fell 3% to the current level. The 5‑day change of –2.04% for the stock versus –5.45% for the S&P 500 and –5.52% for XLV shows that the broader market and sector were the primary drivers of the recent decline, while the stock itself held up better than both.

Analyst consensus remains a “Buy” with a mean target of CHF 726.6, implying a 10.2% discount to that target. The spread between the low target (CHF 550) and the high target (CHF 887) reflects a wide valuation range, but the median still suggests ample upside from the current price.

There is no published dissenting view in the news feed. The only debate that could arise is whether the aggressive capex plan will strain cash flow before the anticipated revenue tailwinds materialise. Even if cash‑flow concerns temper enthusiasm, the structural price levels and breakout math keep the bullish case intact.

What the evidence says

The long‑term thesis remains solid. The price sits above its 40‑week average, the 50‑day simple moving average (CHF 608.4) is well under the current level, and the 200‑day average (CHF 546.8) is far lower, confirming an uptrend that has persisted for months. The stock is 39.8% above its 52‑week low, and the RSI at 56 indicates no extreme overbought condition. In short, the fundamentals that supported the prior bullish stance are unchanged.

For the next two‑to‑six weeks the balance of evidence leans strongly positive, matching the high conviction in the assessment. The daily trend follows the weekly uptrend, the stock is leading both the S&P 500 and XLV over the past 50 days, and the breakout math shows a potential move to CHF 750 with a reward‑to‑risk of 3.1. The only credible counter‑argument is the recent volume weakness – volume is 48.6% below its 20‑day average – which could limit the speed of any upside. That shortfall does not overturn the bullish reading, but it keeps conviction just short of absolute certainty.

Levels that matter

The structure holds the price above CHF 650, a round level that also marks the first crack point in the assessment. Below that, the next structural support is the 50‑day average at CHF 608.4, followed by a swing‑zone floor at CHF 593.5. A weekly close under CHF 593.5 would signal that the uptrend has ended and could trigger a re‑evaluation of the thesis.

The breakout level is a daily close above CHF 672.4 (the 52‑week high) on volume exceeding the 20‑day average. The stop is set at CHF 647.2, derived from a round CHF 650 minus a quarter of the 14‑day ATR (CHF 11.2). The first target is CHF 700 (reward‑to‑risk 1.1) and the second target is CHF 750 (reward‑to‑risk 3.1). Because the math meets a 3‑to‑1 ratio, the upside potential comfortably exceeds the risk.

What would change the picture

A weekly close below the swing‑zone level of CHF 593.5 would invalidate the current outlook, as the assessment specifies that a close under that level would end the uptrend. A material negative earnings surprise on January 28, 2027 – the next earnings date – could also shift sentiment dramatically.

What to watch

Get a message when the LONN.SW picture changes — the agent team watches the levels and the news for you.Create a free account

More LONN.SW analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.